Back

Evaluation of the association between right ventricular lead placement and future need for upgrade from pacemaker or ICD to cardiac resynchronization therapy. A population-based comparative study

26 August 2022 (08:00 - 19:30)
Organised by:
Congress Presentation Part of: Pacing innovations Cardiac Resynchronisation Therapy (CRT) ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Associate Professor Rasmus Borgquist

Novo Nordisk Foundation, Copenhagen (Denmark)

5 More presentations in this session

Presentation thumbnail
Clinical impact of "minimal" right ventricular pacing on atrial arrhythmias: results from the prospective multi-center worldwide EMERALD study.
Doctor A. Di Cori (Pisa, IT)
Abstract Slides Video
Presentation thumbnail
Mortality and 30-day readmission rate following leadless pacemaker implantation: insights from the Nationwide Readmissions Database
Doctor R. Tonegawa-Kuji (Suita, JP)
Abstract Slides Video
Presentation thumbnail
Chronic outcomes of leadless vs transvenous single chamber ventricular pacemakers in high-risk subgroups
Mr L. Higuera (Mounds View, US)
Abstract Slides Video
Presentation thumbnail
Acute hemodynamic effects of biventricular pacing studied during cardiovascular magnetic resonance imaging: The PICARIA Trial
Mr L. Hopman (Amsterdam, NL)
Abstract Slides Video
Presentation thumbnail
Intracardiac echocardiographically guided permanent pacemaker implantation is a feasible imaging tool with comparable procedural efficacy and safety
Professor S. Shin (Ansan, KR)
Abstract Slides Video

Access the full session

Session thumbnail
Pacing innovations

The Event

Event poster

ESC Congress 2022

26 August - 29 August 2022
You may be interested in
thumbnail
Congress Presentation
Impact of left ventricular lead position on echocardiographic response after upgrading from right to biventricular pacing - Insights from the BUDAPEST CRT Upgrade Trial
thumbnail
Congress Presentation
Conduction system versus right ventricular pacing for bradycardia treatment; 1 year outcomes of a prospective, randomized trial in patients with advanced AV disease
thumbnail
Congress Presentation
Timing of cardiac resynchronization therapy after optimal medical therapy in patients with heart failure: temporal trends, predictors and association with outcomes

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources